216 related articles for article (PubMed ID: 30782931)
1. Specific growth rates calculated from CTs in patients with head and neck squamous cell carcinoma: a retrospective study performed in Austria.
Dejaco D; Steinbichler T; Schartinger VH; Fischer N; Anegg M; Dudas J; Posch A; Widmann G; Riechelmann H
BMJ Open; 2019 Feb; 9(2):e025359. PubMed ID: 30782931
[TBL] [Abstract][Full Text] [Related]
2. Approximation of head and neck cancer volumes in contrast enhanced CT.
Dejaco D; Url C; Schartinger VH; Haug AK; Fischer N; Riedl D; Posch A; Riechelmann H; Widmann G
Cancer Imaging; 2015 Sep; 15():16. PubMed ID: 26419914
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.
Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA
Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958
[TBL] [Abstract][Full Text] [Related]
4. FMISO-PET-based lymph node hypoxia adds to the prognostic value of tumor only hypoxia in HNSCC patients.
Bandurska-Luque A; Löck S; Haase R; Richter C; Zöphel K; Abolmaali N; Seidlitz A; Appold S; Krause M; Steinbach J; Kotzerke J; Zips D; Baumann M; Troost EGC
Radiother Oncol; 2019 Jan; 130():97-103. PubMed ID: 30293643
[TBL] [Abstract][Full Text] [Related]
5. HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Linge A; Lohaus F; Löck S; Nowak A; Gudziol V; Valentini C; von Neubeck C; Jütz M; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Buchholz F; Aust DE; Baretton GB; Thames HD; Dubrovska A; Alsner J; Overgaard J; Krause M; Baumann M;
Radiother Oncol; 2016 Dec; 121(3):364-373. PubMed ID: 27913065
[TBL] [Abstract][Full Text] [Related]
6. Histological features and prognostic significance of treatment effect in lymph node metastasis in head and neck squamous cell carcinoma.
Scherpelz KP; Wong AC; Lingen MW; Taxy JB; Cipriani NA
Histopathology; 2019 Jan; 74(2):321-331. PubMed ID: 30144145
[TBL] [Abstract][Full Text] [Related]
7. Can radiological changes in lymph node volume during treatment predict success of radiation therapy in patients with locally advanced head and neck squamous cell carcinoma?
Mishra S; Hammond A; Read N; Venkatesan V; Winquist E; Nichols A; Warner A; Palma D
J Med Imaging Radiat Oncol; 2013 Oct; 57(5):603-9. PubMed ID: 24119277
[TBL] [Abstract][Full Text] [Related]
8. A Scoring System for Prediction of Cervical Lymph Node Metastasis in Patients with Head and Neck Squamous Cell Carcinoma.
Chung MS; Choi YJ; Kim SO; Lee YS; Hong JY; Lee JH; Baek JH
AJNR Am J Neuroradiol; 2019 Jun; 40(6):1049-1054. PubMed ID: 31072971
[TBL] [Abstract][Full Text] [Related]
9. Eps8 expression is significantly lower in p16
Nasri E; Wiesen LB; Knapik JA; Fredenburg KM
Hum Pathol; 2018 Feb; 72():45-51. PubMed ID: 29107665
[TBL] [Abstract][Full Text] [Related]
10. Analysis of lymphatic metastasis and progression patterns for clinical target volume (CTV) definition in head and neck squamous cell carcinoma (HNSCC).
Pouymayou B; Koechli C; Balermpas P; Guckenberger M; Unkelbach J
Acta Oncol; 2019 Oct; 58(10):1519-1522. PubMed ID: 31364898
[No Abstract] [Full Text] [Related]
11. Diagnosis of cervical lymph node metastases in head and neck cancer with ultrasonic measurement of lymph node volume.
Nishio N; Fujimoto Y; Hiramatsu M; Maruo T; Tsuzuki H; Mukoyama N; Yokoi S; Wada A; Kaneko Furukawa M; Furukawa M; Sone M
Auris Nasus Larynx; 2019 Dec; 46(6):889-895. PubMed ID: 30857763
[TBL] [Abstract][Full Text] [Related]
12. Different approaches to volume assessment of lymph nodes in computer tomography scans of head and neck squamous cell carcinoma in comparison with a real gold standard.
Mueller S; Wichmann G; Dornheim L; Roessling I; Bertolini J; Preim B; Dietz A; Boehm A
ANZ J Surg; 2012 Oct; 82(10):737-41. PubMed ID: 22957887
[TBL] [Abstract][Full Text] [Related]
13. Glycoprotein Nonmetastatic Melanoma Protein B as Potential Imaging Marker in Posttherapeutic Metastatic Head and Neck Cancer.
van Schaik JE; Hanemaaijer SH; Halmos GB; Witjes MJH; van der Laan BFAM; van der Vegt B; Plaat BEC
Otolaryngol Head Neck Surg; 2020 Dec; 163(6):1202-1208. PubMed ID: 32600105
[TBL] [Abstract][Full Text] [Related]
14. Use of Diffusion-Weighted Imaging and
Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
[TBL] [Abstract][Full Text] [Related]
15. Correlation of Computerized Tomography density patterns of lymph nodes with treatment results and outcome in head and neck cancer patients treated by 2 different chemoradiotherapy schedules.
Jaju S; Gupta SK; Pandey S; Singh V
J Cancer Res Ther; 2014; 10(2):284-93. PubMed ID: 25022379
[TBL] [Abstract][Full Text] [Related]
16. CD44 variant isoforms in head and neck squamous cell carcinoma progression.
Wang SJ; Wong G; de Heer AM; Xia W; Bourguignon LY
Laryngoscope; 2009 Aug; 119(8):1518-30. PubMed ID: 19507218
[TBL] [Abstract][Full Text] [Related]
17. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
[TBL] [Abstract][Full Text] [Related]
18. Associations Between [
Surov A; Meyer HJ; Höhn AK; Winter K; Sabri O; Purz S
Mol Imaging Biol; 2019 Apr; 21(2):368-374. PubMed ID: 29931433
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of lymph node-DTCs in patients with node-negative HNSCC.
Sproll C; Freund AK; Hassel A; Hölbling M; Aust V; Storb SH; Handschel J; Teichmann C; Depprich R; Behrens B; Neves RP; Kübler NR; Kaiser P; Baldus SE; Tóth C; Kaisers W; Stoecklein NH
Int J Cancer; 2017 May; 140(9):2112-2124. PubMed ID: 28120418
[TBL] [Abstract][Full Text] [Related]
20. Role of primary tumor volume and metastatic lymph node volume in response to curative effect of definitive radiotherapy for locally advanced head and neck cancer.
Mao W; Zhang T; Li L; Peng S; Gong H; Li M
Eur J Med Res; 2024 Feb; 29(1):98. PubMed ID: 38311769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
